KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetLoans - NetLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtOther Non-Current AssetsPayablesReal Estate - GrossReal Estate - NetReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Omega Healthcare Investors (OHI) Retained Earnings (2016 - 2026)

Omega Healthcare Investors' Retained Earnings history spans 17 years, with the latest figure at $54.0 million for Q1 2026.

  • On a quarterly basis, Retained Earnings fell 98.71% to $54.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $54.0 million, a 98.71% decrease, with the full-year FY2025 number at $79.0 million, down 98.07% from a year prior.
  • Retained Earnings hit $54.0 million in Q1 2026 for Omega Healthcare Investors, down from $79.0 million in the prior quarter.
  • Over the last five years, Retained Earnings for OHI hit a ceiling of $4.5 billion in Q3 2025 and a floor of $20.3 million in Q4 2022.
  • Historically, Retained Earnings has averaged $2.3 billion across 5 years, with a median of $3.3 billion in 2022.
  • Biggest five-year swings in Retained Earnings: skyrocketed 229765.99% in 2022 and later plummeted 99.33% in 2023.
  • Tracing OHI's Retained Earnings over 5 years: stood at $20.3 million in 2022, then skyrocketed by 44.34% to $29.3 million in 2023, then skyrocketed by 13830.42% to $4.1 billion in 2024, then crashed by 98.07% to $79.0 million in 2025, then crashed by 31.67% to $54.0 million in 2026.
  • Business Quant data shows Retained Earnings for OHI at $54.0 million in Q1 2026, $79.0 million in Q4 2025, and $4.5 billion in Q3 2025.